logo-loader

Tesla reveals Model 3 launch date as Q4 misses

Last updated: 08:04 11 Feb 2016 EST, First published: 03:04 11 Feb 2016 EST

tesla_factory
Tesla has rapidly become one of the most high-profile companies around - Pic Shutterstock

The hotly anticipated Model 3, the latest car from the Tesla (NASDAQ:TSLA) stable,  will go on sale from March 31, the electric car manufacturer revealed, as it promised it would start turning a profit in 2016.

Entrepreneur Elon Musk, who heads Tesla, said the California-based company would make its first net profit by the fourth quarter this year.

It plans to invest US$1.5 billion to add capacity and start production at a huge mega battery factory in the Nevada desert.

It came as results for the latest fourth quarter showed increased losses, but despite that, the market cheered and shares shot up as much as 10% in after hours trading.

The price rise may have been down to the fact that despite the loss of money there has been no let-up in production at the firm,

Tesla said it expects to ship 80,000 to 90,000 Model S and Model X cars in 2016, beating forecasts that the company would only ship about 76,000.

But it’s not been an easy period for the company.

The firm has been hit by various factors, including a slump in the oil price, potentially making conventional gasoline (or petrol) cheaper, along with general malaise in the global outlook.

There is also a certain amount of uncertainty about the source for all the lithium required to make its batteries.

The Latest Model 3 will be unveiled to the public on March 31, Musk announced to shareholders at the company’s quarterly earnings call.

With a price tag of US$35,000, half the cost of the previous Model S, it is intended to be Tesla’s first moderately priced car.

But reportedly that  price tag is likely to be reduced further by government subsidies for electric vehicles in place around the world.

The best production estimates have the Model 3 arriving towards the end of 2017.

The group reported a fourth-quarter adjusted loss of 87 cents per share on US$1.75bln in sales. Analysts at Thomson Reuters had expected Tesla to post earnings of 10 cents per share on US$1.79bln revenue.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

25 minutes ago